Ambulatory infusion centers provide convenient treatment options for patients suffering from chronic diseases like cancer, congestive heart failure, Crohn's disease, etc. through intravenous administration of drugs, fluids, and nutrients on an outpatient basis. This reduces unnecessary hospital stays and related costs. The growing geriatric population prone to chronic illnesses has increased the need for ambulatory infusion services. The global Ambulatory Infusion Center Market is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising prevalence of chronic and life-threatening diseases has driven the demand for ambulatory infusion services over the years. As per several studies, chronic diseases account for approximately 60% of all deaths globally each year, with cancer and cardiovascular conditions being the leading causes. Ambulatory infusion facilities allow chronic disease patients to receive infusions periodically without being admitted, saving them time and money spent on hospital resources. This has boosted the patronage for ambulatory infusion centers. Their focus on providing advanced and specialized treatment in a convenient outpatient setup is expected to further aid the growth of this market over the forecast period.
Segment Analysis
The Global Ambulatory Infusion Center Market Analysis is dominated by the chemotherapy segment. Chemotherapy is a systematic treatment procedure that involves the use of anti-cancer drugs to kill cancer cells. The segment accounts for the largest market share due to the high prevalence of chemotherapy treatment among cancer patients.
Key Takeaways
The global ambulatory infusion center market is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: North America currently dominates the global market and is expected to continue its dominance over the forecast period. This can be attributed to the well-developed healthcare infrastructure and increasing incidence of chronic diseases in the region. According to estimates, the North American ambulatory infusion center market is projected to reach US$ 27,111.67 Mn by 2030 at a CAGR of 12.2%.
Key players operating in the ambulatory infusion center market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., DJO Global, Inc., Össur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., Bioventus LLC. Johnson & Johnson (DePuy Synthes) currently dominates the market due to its robust product portfolio and global presence.
Get more insights on this topic: https://www.trendingwebwire.com/ambulatory-infusion-center-market-size-and-share-analysis-growth-trends-and-forecasts/
Explore more information on this topic, Please visit: https://www.newsintv.com/health/cell-and-gene-therapy-revolutionizing-medical-science/
The Ambulatory Infusion Center market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the ambulatory infusion center market include Option Care Health, UnitedHealth Group, Cleveland Clinic, HCA Healthcare, UK HealthCare, Coram CVS, McLaren, Accredo Health, CHI Health, PharMerica.S.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Ambulatory Infusion Center Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/ambulatory-infusion-center-market/download-sampleMarket DynamicsThe rising geriatric population with decreased mobility profile across the globe is the primary factor driving the ambulatory infusion center market.
Also, rapid technological advancements and a rise in government initiatives to enhance health care facilities focus on research and an increase in research funding, thus contributing to the ambulatory infusion center market's growth.
The growing prevalence of cancer, multiple sclerosis, renal failure, and hemophilia, among others, is positively impacting the ambulatory infusion center market's growth.
